Additional Metadata
Persistent URL dx.doi.org/10.1093/annonc/mdy284.022, hdl.handle.net/1765/125543
Journal Annals of Oncology
Citation
Robbrecht, D.G. (D. G.), van Soest, R.J, Tannock, I.F, Oudard, S, Tombal, B, Eisenberger, M.A, … de Wit, R. (2018). Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment. Annals of Oncology, 29, viii281–viii282. doi:10.1093/annonc/mdy284.022